Pharma Foods, Aug-Oct (1Q) Ordinary Profit Turns to Loss

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Dec 11, 2025 1:30 pm JST Earnings

2929 Pharma Foods International Co., Ltd. 【J-GAAP】

Earnings Report

Pharma Foods International Co., Ltd. <2929> [TSE Prime] announced its financial results in the afternoon session on December 11th (13:30). The consolidated ordinary profit/loss for the first quarter of the fiscal year ending July 2026 (August to October) turned into a loss of 2.64 billion yen (compared to a profit of 0.88 billion yen in the same period last year).

In the most recent three-month period, from August to October (1Q), the operating profit/loss margin drastically worsened from 6.0% in the same period last year to -16.0%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Aug - Oct, 2023	16,142	601	605	286	9.9	39.2	Dec 11, 2023	J-GAAP
Aug - Oct, 2024	14,596	882	888	360	12.9	137.7	Dec 11, 2024	J-GAAP
Aug - Oct, 2025	15,712	-2,511	-2,644	-1,891	-65.5	ー	Dec 11, 2025	J-GAAP
YoY	+7.6%	－	－	－	－

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Aug - Jan, 2024	29,857	623	645	229	8.1	12.50	Mar 12, 2025	J-GAAP
Aug - Jan, 2025 Guidance	ー	ー	ー	ー	－	12.50	Sep 11, 2025	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul, 2024	62,147	5,113	5,249	3,205	112.7	25	Sep 12, 2024	J-GAAP
Jul, 2025	65,260	2,367	2,553	368	12.8	25	Sep 11, 2025	J-GAAP
Jul, 2026 Guidance	68,000	1,500	1,500	1,000	34.4	25	Sep 11, 2025	J-GAAP
YoY	+4.2%	-36.6%	-41.2%	+171.7%	+168.0%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Aug - Oct, 2024	14,596	882	888	360	12.9	6.0	Dec 11, 2024	J-GAAP
Nov - Jan, 2024	15,261	-259	-243	-131	-4.6	-1.7	Mar 12, 2025	J-GAAP
Feb - Apr, 2025	16,960	-840	-876	-1,352	-47.2	-5.0	Jun 10, 2025	J-GAAP
May - Jul, 2025	18,443	2,584	2,784	1,491	52.0	14.0	Sep 11, 2025	J-GAAP
Aug - Oct, 2025	15,712	-2,511	-2,644	-1,891	-65.5	-16.0	Dec 11, 2025	J-GAAP
YoY	+7.6%	－	－	－	－